Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... Chimerix, Inc., a biopharmaceutical company advancing orally-available antiviral therapeutics to address life-threatening diseases, announced that Kenneth I. Moch, Chief ... Drugs, Pharmaceuticals, Therapies, Treatment, Viral Inhibition, Viral Therapy, Virology, Chimerix Inc. This article was prepared by Biotech Business Week ...
2009 NOV 23 ... certain key hydrogen atoms of atazanavir with deuterium. In preclinical studies, the antiviral potency of atazanavir was fully retained but with markedly slower hepatic metabolism, ... inhibitors. Our goal is to provide patients with a potent and well-tolerated once-daily therapy without the side effects, inconvenience and expense of an additional drug." ...
2009 NOV 23 ... Sweden report. "Combination therapy including LV-antiserum and an antiviral drug, Pleconaril, significantly reduced the levels of blood glucose and insulin and the ...
2009 NOV 28 ... continue to make progress on all fronts, including the advancement of our differentiated antiviral development programs and most recently, the completion of a financing that we believe ... in Phase I studies, supports the potential of FV-100 as a highly potent, once-daily oral therapy to reduce the incidence and severity of shingles-related symptoms, including acute pain ...
2009 NOV 23 ... is a discovery-stage biotechnology company focused on the development of new types of antiviral and autoimmune drugs. The Kineta team has a track record of developing novel drug ... Diseases, Oncology, Pharmaceuticals, Pharmacology, Pre-Trials Research, Retinoic Acid, Therapy, Treatment, Vaccines, Virology, Kineta Inc. This article was prepared by ...
2009 NOV 23 ... fusion inhibitor, now called MDT-637. This highly potent compound has demonstrated antiviral activity in preclinical studies in both prophylaxis and treatment, and was generally ... Research, Premature Infant, Pulmonology, Respiratory Syncytial Virus, Respiratory Tract, Therapy, Treatment, Viral, Viral Inhibition, Viral Therapy, ViroPharma Incorporated, Virology, ...
2009 NOV 27 ... concluded: "The prepared family of the target nucleosides was tested for cytostatic and antiviral activity."Sala and colleagues published their study in Tetrahedron ... Country:Czech Republic, Life Sciences, Virology, Coxsackie Virus, Viral Research, Therapy, Treatment, Nucleoside Analog, Organic Chemistry.This article was prepared ...
2009 NOV 23 ... The researchers concluded: "Following the demonstration of a more potent antiviral effect in terms of sustained virological response rates in Phase III randomized trials, ... Aghemo and colleagues published their study in Expert Review of Anti - Infective Therapy (Pegylated IFN-alpha 2a and ribavirin in the treatment of hepatitis C. Expert Review of ...
2009 NOV 23 ... for testing and biosafety requirements necessary to safely handle it, In this study, the antiviral activity of standard household products was assayed against murine hepatitis virus ... Disease, SARS, Severe Acute Respiratory Syndrome, Treatment, Viral Inhibition, Viral Therapy, Virology. This article was prepared by Biotech Business Week editors from ...
2009 NOV 23 ... Affairs. "These data support the unique dual activities of DAS181. Because of its antiviral and anti-asthmatic properties, DAS181 may provide an alternative influenza treatment ... Pandemics, Paramyxoviridae, Paramyxovirus, Pharmaceuticals, Swine Flu, Swine Influenza, Therapy, Treatment, Virology, NexBio Inc. This article was prepared by Biotech ...
2009 NOV 23 ... derived from lymphocytic choriomeningitis virus (LCMV) and evaluated its potency as an antiviral vaccine. The intramuscular immunization of mice with the peptide-liposome conjugates ... Antiviral, Biotechnology, Immunology, Treatment, Vaccines, Viral Inhibition, Viral Therapy, Virology. This article was prepared by Biotech Business Week editors from ...
2009 NOV 23 ... "A small-animal model for HCV infection would significantly expedite antiviral compound development and preclinical testing, as well as open new avenues to decipher ... and affects an estimated 3% of the world's population. Options for the prevention or therapy of HCV infection are limited; there is no vaccine and the nonspecific, interferon-based ...
2009 NOV 23 ... treatment of multiple sclerosis (MS). it is believed that immunomodulatory rather than antiviral activity of interferon beta is responsible for disease amelioration. The impact of ... study in Archives of Neurology (Enhancement of Chemokine Expression by Interferon Beta Therapy in Patients With Multiple Sclerosis. Archives of Neurology, 2009;66(10):1216-1223). ...
2009 NOV 23 ... Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Antimetabolite, Antineoplastic, Antiviral, Breast Cancer, Breast Carcinoma, Clinical Oncology, Clinical Trial Research, ... St., Oxford OX2 6DP, England. Keywords: Japan, Isehara, Breast Cancer Therapy, Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Antimetabolite, ...
2009 NOV 23 ... nonstructural proteins, have been shown to have oncogenic properties. For HBV infection, antiviral therapy and vaccination have been shown to decrease the risk of HCC," wrote J. Fung and ...
2009 NOV 23 ... use disorders, patients with these comorbidities have historically been excluded from antiviral therapy for HCV. The authors compared antiviral completion and sustained virologic response ...
2009 NOV 23 ... (RAMs) were investigated by analysing 6072 genotypic tests." "The antiviral activity of ETV was predicted using different interpretation systems: International AIDS ... Main St., Malden, MA 02148, USA. Keywords: Switzerland, Zurich, HIV/AIDS Therapy, AIDS, Acquired Immunodeficiency Syndrome, Antiviral, Clinical Trial Research, Drug ...
